tiprankstipranks
Advertisement
Advertisement

Moolec Science Receives New Nasdaq Non-Compliance Notice, Plans Accounting Gain to Restore Listing Status

Story Highlights
  • Moolec received a Nasdaq letter on December 30, 2025, stating it no longer meets the $2.5 million stockholders’ equity requirement.
  • The company plans to regain Nasdaq compliance through an estimated $105.8 million gain from derecognizing bankrupt subsidiaries, boosting net income above listing thresholds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Moolec Science Receives New Nasdaq Non-Compliance Notice, Plans Accounting Gain to Restore Listing Status

Meet Samuel – Your Personal Investing Prophet

Moolec Science ( (MLEC) ) has provided an update.

On December 30, 2025, Moolec Science SA received an additional determination letter from Nasdaq’s Listing Qualifications Department stating that the company no longer meets the minimum stockholders’ equity requirement of $2.5 million under Listing Rule 5550(b)(1). As previously disclosed in its Form 20-F for the year ended June 30, 2025, Moolec’s management expects to regain compliance with Nasdaq’s continued listing standards through recognition of an estimated $105.8 million gain from the derecognition of certain subsidiaries that entered bankruptcy, a process that is already underway. The company anticipates that this accounting gain will result in positive net income sufficient to satisfy Nasdaq’s $500,000 net income standard, and it made this disclosure in line with Nasdaq’s requirement for prompt public notice after a non-compliance notification, signaling an important phase in Moolec’s efforts to secure its continued listing and reassure investors about its regulatory standing.

The most recent analyst rating on (MLEC) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Underperform.

Moolec Science faces significant financial challenges with negative profitability and cash flow issues despite revenue growth. The technical analysis is bearish, and the valuation appears unfavorable with a negative P/E ratio. These factors contribute to a low overall stock score, highlighting the need for improved financial performance and market sentiment.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science SA is a foreign private issuer listed on Nasdaq and domiciled in the Cayman Islands. The company operates in the agri-food and food technology sector, focusing on innovative ingredients and related science-driven solutions, and is subject to U.S. securities regulation as a Nasdaq-listed firm filing annual reports on Form 20-F.

Average Trading Volume: 275,146

Technical Sentiment Signal: Sell

Current Market Cap: $2.76M

For a thorough assessment of MLEC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1